- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x P33: 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL(Non-covalent)
- 4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
FDA.2: 27 residues within 4Å:- Chain A: I.121, G.122, A.123, S.124, G.129, S.130, F.154, S.156, K.200, T.208, L.354, V.357, G.359, T.361, E.363
- Chain B: R.266, Q.268, F.269, L.273, H.276, L.279, H.331, I.332, G.334, G.335
- Chain D: Q.277
- Ligands: P33.1
28 PLIP interactions:16 interactions with chain A, 10 interactions with chain B, 2 interactions with chain D- Hydrophobic interactions: A:F.154, A:F.154, A:K.200, A:T.208
- Hydrogen bonds: A:I.121, A:A.123, A:S.124, A:S.124, A:S.124, A:S.130, A:S.130, A:S.156, A:G.359, A:G.360, A:T.361, A:T.361, B:Q.268, B:H.331, B:G.335, D:Q.277
- Water bridges: B:R.262, B:R.266, B:R.266, B:A.336, D:Q.277
- Salt bridges: B:R.266, B:R.266
- pi-Stacking: B:H.276
FDA.4: 27 residues within 4Å:- Chain A: R.266, Q.268, F.269, L.273, H.276, L.279, H.331, I.332, G.334, G.335
- Chain B: I.121, A.123, S.124, G.129, S.130, F.154, S.156, K.200, L.354, V.357, G.358, G.359, G.360, T.361, E.363
- Chain C: Q.277
- Ligands: P6G.3
28 PLIP interactions:15 interactions with chain B, 12 interactions with chain A, 1 interactions with chain C- Hydrophobic interactions: B:F.154, B:F.154, B:K.200, B:L.354
- Hydrogen bonds: B:I.121, B:A.123, B:S.124, B:S.124, B:S.124, B:S.130, B:S.156, B:G.359, B:G.360, B:T.361, B:T.361, A:Q.268, A:H.331, A:G.335, C:Q.277
- Water bridges: A:R.262, A:R.266, A:R.266, A:R.266, A:R.266, A:A.336
- Salt bridges: A:R.266, A:R.266
- pi-Stacking: A:H.276
FDA.6: 27 residues within 4Å:- Chain B: Q.277
- Chain C: I.121, G.122, A.123, S.124, G.129, S.130, F.154, S.156, K.200, T.208, L.354, V.357, G.359, T.361, E.363
- Chain D: R.266, Q.268, F.269, L.273, H.276, L.279, H.331, I.332, G.334, G.335
- Ligands: P33.5
27 PLIP interactions:18 interactions with chain C, 8 interactions with chain D, 1 interactions with chain B- Hydrophobic interactions: C:F.154, C:F.154, C:K.200, C:T.208
- Hydrogen bonds: C:I.121, C:A.123, C:S.124, C:S.124, C:S.124, C:S.130, C:S.130, C:S.156, C:G.359, C:G.360, C:T.361, C:E.363, D:Q.268, D:H.331, D:G.335, B:Q.277
- Water bridges: C:E.367, C:E.367, D:R.262, D:A.336
- Salt bridges: D:R.266, D:R.266
- pi-Stacking: D:H.276
FDA.8: 27 residues within 4Å:- Chain A: Q.277
- Chain C: R.266, Q.268, F.269, L.273, H.276, L.279, H.331, I.332, G.334, G.335
- Chain D: I.121, A.123, S.124, G.129, S.130, F.154, S.156, K.200, L.354, V.357, G.358, G.359, G.360, T.361, E.363
- Ligands: P6G.7
28 PLIP interactions:15 interactions with chain D, 12 interactions with chain C, 1 interactions with chain A- Hydrophobic interactions: D:F.154, D:F.154, D:K.200, D:L.354
- Hydrogen bonds: D:I.121, D:A.123, D:S.124, D:S.124, D:S.124, D:S.130, D:S.156, D:G.359, D:G.360, D:T.361, D:E.363, C:Q.268, C:H.331, C:G.335, A:Q.277
- Water bridges: C:R.262, C:R.266, C:R.266, C:R.266, C:R.266, C:A.336
- Salt bridges: C:R.266, C:R.266
- pi-Stacking: C:H.276
- 2 x P6G: HEXAETHYLENE GLYCOL(Non-functional Binders)
P6G.3: 15 residues within 4Å:- Chain B: A.78, A.80, V.84, L.88, S.156, I.244, I.248, S.251, W.348, D.351, L.354, A.355, G.358, G.359
- Ligands: FDA.4
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:L.88
- Hydrogen bonds: B:S.251, B:S.251
P6G.7: 15 residues within 4Å:- Chain D: A.78, A.80, V.84, L.88, S.156, I.244, I.248, S.251, W.348, D.351, L.354, A.355, G.358, G.359
- Ligands: FDA.8
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:L.88
- Hydrogen bonds: D:S.251, D:S.251
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chai, A.F. et al., A covalent adduct of MbtN, an acyl-ACP dehydrogenase from Mycobacterium tuberculosis, reveals an unusual acyl-binding pocket. Acta Crystallogr.,Sect.D (2015)
- Release Date
- 2015-02-11
- Peptides
- Acyl-[acyl-carrier-protein] dehydrogenase MbtN: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x P33: 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL(Non-covalent)
- 4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x P6G: HEXAETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chai, A.F. et al., A covalent adduct of MbtN, an acyl-ACP dehydrogenase from Mycobacterium tuberculosis, reveals an unusual acyl-binding pocket. Acta Crystallogr.,Sect.D (2015)
- Release Date
- 2015-02-11
- Peptides
- Acyl-[acyl-carrier-protein] dehydrogenase MbtN: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B